Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ. Tsai CJ, Huang HY, Chen FM, Yang YH, et al. PLoS One 2022;17:e0262934.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tsai CJ, Huang HY, Chen FM, Yang YH, et al. Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ. PLoS One 2022;17:e0262934.
PMID: 35089956